Uni-Bio Science Group Current Liabilities
The Current Liabilities of Uni-Bio Science Group (690.HK) as of Oct 15, 2026 is 172.16 M HKD. In the previous year, Current Liabilities was 178.12 M HKD — a change of -3.34% (lower).
Get this data via API
Financial Data API
Current Liabilities
172.16 MHKD
YoY
-3.34%
Last updated:
The Uni-Bio Science Group Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 172.16 MHKD | -3.34% | |
| 178.12 MHKD | +97.35% | |
| 90.26 MHKD | -2.22% | |
| 92.30 MHKD | +52.89% | |
| 60.37 MHKD | +10.57% | |
| 54.60 MHKD | +38.30% | |
| 39.48 MHKD | -13.47% | |
| 45.63 MHKD | -8.69% | |
| 49.97 MHKD | +1.06% | |
| 49.44 MHKD | +49.72% | |
| 33.02 MHKD | -64.94% | |
| 94.20 MHKD | +25.27% | |
| 75.20 MHKD | -2.21% | |
| 76.90 MHKD | +7.25% | |
| 71.70 MHKD | -16.92% | |
| 86.30 MHKD | -39.73% | |
| 143.20 MHKD | -31.42% | |
| 208.80 MHKD | +59.15% | |
| 131.20 MHKD | +113.33% | |
| 61.50 MHKD | -31.36% | |
| 89.60 MHKD | -12.59% | |
| 102.50 MHKD | +9.86% | |
| 93.30 MHKD | +93.57% | |
| 48.20 MHKD | -4.17% | |
| 50.30 MHKD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Uni-Bio Science Group Stock analysis
Frequently Asked Questions about Uni-Bio Science Group stock
Current Liabilities of Uni-Bio Science Group is 172.16 M HKD in 2024.
Current Liabilities of Uni-Bio Science Group changed from 178.12 M HKD to 172.16 M HKD, representing a -3.34% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Uni-Bio Science Group since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's HKD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Uni-Bio Science Group historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Uni-Bio Science Group
All Key Metrics — Uni-Bio Science Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth